DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 019967
» See Plans and Pricing
NDA 019967 describes ULTRAVATE, which is a drug marketed by Sun Pharm Inds Inc and Sun Pharm Industries and is included in three NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the ULTRAVATE profile page.
The generic ingredient in ULTRAVATE is halobetasol propionate. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
The generic ingredient in ULTRAVATE is halobetasol propionate. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
Summary for 019967
| Tradename: | ULTRAVATE |
| Applicant: | Sun Pharm Inds Inc |
| Ingredient: | halobetasol propionate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Dec 27, 1990 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 019967
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | CREAM;TOPICAL | 019967-001 | Dec 27, 1990 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
